Suzhou VencuBio Ltd. was established in February 2021, guided by the unmet clinical needs, and is committed to the research and development of innovative drugs. The pipeline currently under research involves tumors, autoimmune diseases, respiratory diseases and other fields.

We are led by a team of scientists and works with professional biomedical investment institutions to create a unique innovative drug incubation platform in China. The company has gathered industry elites and formed an innovation team covering the whole process of innovative drug research and development, intellectual property protection, CMC, drug registration declaration, drug clinical research, business development and so on.